Special Issue "Digital Transformation of Psychiatric Medicine in Post-COVID-19"

A special issue of Psychiatry International (ISSN 2673-5318).

Deadline for manuscript submissions: 31 December 2021.

Special Issue Editors

Prof. Dr. Roger C.M. Ho
E-Mail Website
Guest Editor
Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Kent Ridge 119228, Singapore
Interests: medical aspects of depressive disorder; psychiatric aspects of medical disorders; functional near infrared spectroscopy; meta-analysis; suicide and deliberate self-harm
Special Issues, Collections and Topics in MDPI journals
Dr. Yoshihiro Noda
E-Mail Website
Guest Editor
Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Interests: neuroplasticity; neuromodulation; neurophysiology; TMS; EEG; TMS-EEG; TMS-EMG; MRI; MRS; omics; neuroinformatics; database
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

COVID-19 (SARS-CoV-2) first appeared in late 2019 and its rapid spread around the world has killed hundreds of thousands of people, infected many more, and triggered historic quarantine measures to keep vulnerable people safe. On March 11, 2020, the Director-General of the World Health Organization finally announced that the COVID-19 epidemic was to be considered a pandemic.

The COVID-19 pandemic has caused major lifestyle changes throughout society worldwide, and its impact on psychiatric care is no exception. In fact, the digitalization of medical care, including telemedicine, which had been severely restricted by various regulations and conservative ideas in the past, is now experiencing a period of change, as social legitimacy and rationality are now assured after the COVID-19 pandemic.

For this Special Issue in Psychiatry International, we are looking for submissions regarding the following topics in relation to the digitalization of psychiatric care: 1) biological research, 2) IT development research, 3) database development research, and 4) epidemiological research. We will accept a wide range of paper formats, from original research, methodology papers, commentaries, and review papers.

Prof. Dr. Roger C.M. Ho
Dr. Yoshihiro Noda
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Psychiatry International is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • post-COVID-19
  • digitalization
  • data science
  • social development goals
  • 5G

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


Neurodevelopmental Disorders Induced by Maternal Immune Activation: Toward a Prevention Strategy in the Era of the COVID-19 Pandemic
Psychiatry Int. 2020, 1(1), 24-26; https://0-doi-org.brum.beds.ac.uk/10.3390/psychiatryint1010003 - 18 Aug 2020
Viewed by 932
As of summer 2020, the COVID-19 pandemic is having a major impact on our daily lives on a global scale, forcing us to change to the new normal. However, the effects are not only detrimental to our present socioeconomic conditions but also have [...] Read more.
As of summer 2020, the COVID-19 pandemic is having a major impact on our daily lives on a global scale, forcing us to change to the new normal. However, the effects are not only detrimental to our present socioeconomic conditions but also have the risk of having negative biological effects on our descendants. Of concern is the effect of maternal immune activation following maternal infection with COVID-19 on the fetus’ cerebral nervous system. While we are currently occupied with countering the imminent threats in front of us, we also need to take steps from a public health perspective to reduce the impact of maternal infection on the fetus, especially the risk of neurodevelopmental disorders. However, such a risk can be prevented and managed through the digital transformation of the nation’s health data and the strategic application of sophisticated data science approaches to those big data. Full article
(This article belongs to the Special Issue Digital Transformation of Psychiatric Medicine in Post-COVID-19)
Back to TopTop